ALIGN TECHNOLOGY, INC. Selling, General and Administrative Expense
ALIGN TECHNOLOGY, INC. (ALGN) reported Selling, General and Administrative Expense of $462.67 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-05
- ALIGN TECHNOLOGY, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $462.67M, a 3.12% increase year-over-year.
- ALIGN TECHNOLOGY, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $465.34M, a 3.96% increase year-over-year.
- ALIGN TECHNOLOGY, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $441.68M, a 3.93% increase year-over-year.
- ALIGN TECHNOLOGY, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $417.80M, a 3.76% decline year-over-year.
- ALIGN TECHNOLOGY, INC. selling, general and administrative expense for fiscal 2025 was $1.76B, a 0.42% decline from fiscal 2024.
- ALIGN TECHNOLOGY, INC. selling, general and administrative expense for fiscal 2024 was $1.76B, a 3.51% increase from fiscal 2023.
- ALIGN TECHNOLOGY, INC. selling, general and administrative expense for fiscal 2023 was $1.70B, a 1.73% increase from fiscal 2022.
- ALIGN TECHNOLOGY, INC. selling, general and administrative expense for fiscal 2022 was $1.67B, a 2.00% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $462.67M 10-Q · filed 2026-08-05 | $928.01M 10-Q · filed 2026-08-05 | $1.37B derived: sum of 3 quarters · filed 2026-08-05 | $1.79B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $465.34M 10-Q · filed 2026-05-06 | $907.02M derived: sum of 2 quarters · filed 2026-05-06 | $1.32B derived: sum of 3 quarters · filed 2026-05-06 | $1.77B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $441.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $859.48M derived: sum of 2 quarters · filed 2026-02-27 | $1.31B derived: sum of 3 quarters · filed 2026-08-05 | $1.76B 10-K · filed 2026-02-27 |
| 2025-09-30 | $417.80M 10-Q · filed 2025-11-05 | $866.49M derived: sum of 2 quarters · filed 2026-08-05 | $1.31B 10-Q · filed 2025-11-05 | $1.74B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $448.69M 10-Q · filed 2026-08-05 | $896.32M 10-Q · filed 2026-08-05 | $1.32B derived: sum of 3 quarters · filed 2026-08-05 | $1.76B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $447.63M 10-Q · filed 2026-05-06 | $872.60M derived: sum of 2 quarters · filed 2026-05-06 | $1.31B derived: sum of 3 quarters · filed 2026-05-06 | $1.76B derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $424.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $859.11M derived: sum of 2 quarters · filed 2026-02-27 | $1.31B derived: sum of 3 quarters · filed 2026-02-27 | $1.76B 10-K · filed 2026-02-27 |
| 2024-09-30 | $434.14M 10-Q · filed 2025-11-05 | $886.40M derived: sum of 2 quarters · filed 2025-11-05 | $1.34B 10-Q · filed 2025-11-05 | $1.74B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $452.26M 10-Q · filed 2025-08-06 | $904.08M 10-Q · filed 2025-08-06 | $1.31B derived: sum of 3 quarters · filed 2026-02-27 | $1.71B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $451.82M 10-Q · filed 2025-05-08 | $854.33M derived: sum of 2 quarters · filed 2026-02-27 | $1.26B derived: sum of 3 quarters · filed 2026-02-27 | $1.72B derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $402.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $810.50M derived: sum of 2 quarters · filed 2026-02-27 | $1.26B derived: sum of 3 quarters · filed 2026-02-27 | $1.70B 10-K · filed 2026-02-27 |
| 2023-09-30 | $407.99M 10-Q · filed 2024-11-05 | $861.18M derived: sum of 2 quarters · filed 2024-11-05 | $1.30B 10-Q · filed 2024-11-05 | $1.71B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $453.19M 10-Q · filed 2024-08-02 | $892.88M 10-Q · filed 2024-08-02 | $1.30B derived: sum of 3 quarters · filed 2025-02-28 | $1.70B derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $439.69M 10-Q · filed 2024-05-03 | $849.76M derived: sum of 2 quarters · filed 2025-02-28 | $1.25B derived: sum of 3 quarters · filed 2025-02-28 | $1.67B derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $410.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $808.61M derived: sum of 2 quarters · filed 2025-02-28 | $1.24B derived: sum of 3 quarters · filed 2025-02-28 | $1.67B 10-K · filed 2025-02-28 |
| 2022-09-30 | $398.55M 10-Q · filed 2023-11-03 | $824.95M derived: sum of 2 quarters · filed 2023-11-03 | $1.26B 10-Q · filed 2023-11-03 | $1.72B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $426.40M 10-Q · filed 2023-08-04 | $865.86M 10-Q · filed 2023-08-04 | $1.32B derived: sum of 3 quarters · filed 2024-02-28 | $1.75B derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $439.46M 10-Q · filed 2023-05-05 | $890.65M derived: sum of 2 quarters · filed 2024-02-28 | $1.32B derived: sum of 3 quarters · filed 2024-02-28 | $1.75B derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $451.19M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $879.60M derived: sum of 2 quarters · filed 2024-02-28 | $1.31B derived: sum of 3 quarters · filed 2024-02-28 | $1.71B 10-K · filed 2024-02-28 |
| 2021-09-30 | $428.41M 10-Q · filed 2022-11-04 | $860.33M derived: sum of 2 quarters · filed 2022-11-04 | $1.26B 10-Q · filed 2022-11-04 | $1.61B derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $431.92M 10-Q · filed 2022-08-04 | $829.04M 10-Q · filed 2022-08-04 | $1.18B derived: sum of 3 quarters · filed 2023-02-27 | $1.49B derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $397.12M 10-Q · filed 2022-05-05 | $745.51M derived: sum of 2 quarters · filed 2023-02-27 | $1.06B derived: sum of 3 quarters · filed 2023-02-27 | $1.31B derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $348.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $660.88M derived: sum of 2 quarters · filed 2023-02-27 | $917.85M derived: sum of 3 quarters · filed 2023-02-27 | $1.20B 10-K · filed 2023-02-27 |
| 2020-09-30 | $312.49M 10-Q · filed 2021-11-02 | $569.46M derived: sum of 2 quarters · filed 2021-11-02 | $852.37M 10-Q · filed 2021-11-02 | $1.13B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $256.97M 10-Q · filed 2021-08-04 | $539.87M 10-Q · filed 2021-08-04 | $819.35M derived: sum of 3 quarters · filed 2022-02-25 | $1.10B derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $282.91M 10-Q · filed 2021-05-05 | $562.39M derived: sum of 2 quarters · filed 2022-02-25 | $839.90M derived: sum of 3 quarters · filed 2022-02-25 | $1.11B derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $279.48M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $557.00M derived: sum of 2 quarters · filed 2022-02-25 | $824.94M derived: sum of 3 quarters · filed 2022-02-25 | $1.07B 10-K · filed 2022-02-25 |
| 2019-09-30 | $277.51M 10-Q · filed 2020-10-30 | $545.46M derived: sum of 2 quarters · filed 2020-10-30 | $792.57M 10-Q · filed 2020-10-30 | $1.02B derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $267.95M 10-Q · filed 2020-07-31 | $515.06M 10-Q · filed 2020-07-31 | $741.88M derived: sum of 3 quarters · filed 2021-02-26 | $955.75M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $247.11M 10-Q · filed 2020-05-05 | $473.93M derived: sum of 2 quarters · filed 2021-02-26 | $687.80M derived: sum of 3 quarters · filed 2021-02-26 | $899.89M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $226.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $440.69M derived: sum of 2 quarters · filed 2021-02-26 | $652.78M derived: sum of 3 quarters · filed 2021-02-26 | $852.40M 10-K · filed 2021-02-26 |
| 2018-09-30 | $213.87M 10-Q · filed 2019-10-31 | $425.96M derived: sum of 2 quarters · filed 2019-10-31 | $625.59M 10-Q · filed 2019-10-31 | |
| 2018-06-30 | $212.09M 10-Q · filed 2019-08-01 | $411.71M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $199.63M 10-Q · filed 2019-05-02 | |||
| 2017-09-30 | $169.52M 10-Q · filed 2018-11-01 | $332.49M derived: sum of 2 quarters · filed 2018-11-01 | $483.64M 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $162.96M 10-Q · filed 2018-08-02 | $314.11M 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $151.15M 10-Q · filed 2018-05-03 | |||
| 2016-09-30 | $126.71M 10-Q · filed 2017-11-02 | $248.18M derived: sum of 2 quarters · filed 2017-11-02 | $360.38M 10-Q · filed 2017-11-02 | $459.97M derived: sum of 4 quarters · filed 2017-11-02 |
| 2016-06-30 | $121.47M 10-Q · filed 2017-08-03 | $233.68M 10-Q · filed 2017-08-03 | $333.26M derived: sum of 3 quarters · filed 2017-08-03 | $435.01M derived: sum of 4 quarters · filed 2017-08-03 |
| 2016-03-31 | $112.21M 10-Q · filed 2017-05-04 | $211.79M derived: sum of 2 quarters · filed 2017-05-04 | $313.54M derived: sum of 3 quarters · filed 2017-05-04 | $414.17M derived: sum of 4 quarters · filed 2017-05-04 |
| 2015-12-31 | $99.58M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $201.33M derived: sum of 2 quarters · filed 2016-11-08 | $301.96M derived: sum of 3 quarters · filed 2016-11-08 | $390.24M 10-K · filed 2016-02-25 |
| 2015-09-30 | $101.75M 10-Q · filed 2016-11-08 | $202.38M derived: sum of 2 quarters · filed 2016-11-08 | $290.66M 10-Q · filed 2016-11-08 | |
| 2015-06-30 | $100.63M 10-Q · filed 2016-08-04 | $188.91M 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | $88.28M 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $332.07M 10-K · filed 2016-02-25 | |||
| 2013-12-31 | $292.80M 10-K · filed 2016-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B |